Showing 1 - 5 results of 5 for search 'K Hoschler', query time: 0.03s Refine Results
  1. 1
    Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009

    Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009 by P Hardelid, NJ Andrews, K Hoschler, E Stanford, M Baguelin, PA Waight, M Zambon, E Miller

    Published 2010-12-01
    Get full text
    Article
  2. 2
    A randomised, partially observer-blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart

    A randomised, partially observer-blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart by KG Nicholson, KR Abrams, S Batham, TW Clark, K Hoschler, WS Lim, M Medina, JS Nguyen-Van-Tam, RC Read, FC Warren, M Zambon

    Published 2010-12-01
    Get full text
    Article
  3. 3
    Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy

    Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy by RL Puleston, G Bugg, K Hoschler, J Konje, J Thornton, I Stephenson, P Myles, J Enstone, G Augustine, Y Davis, M Zambon, KG Nicholson, JS Nguyen-Van-Tam

    Published 2010-12-01
    Get full text
    Article
  4. 4
    A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children

    A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children by P de Whalley, W Walker, MD Snape, C Oeser, M Casey, P Moulsdale, C Harrill, N Andrews, K Hoschler, B Thompson, C Jones, J Chalk, S Kerridge, R Tomlinson, PT Heath, A Finn, S Faust, E Miller, AJ Pollard

    Published 2011-12-01
    Get full text
    Article
  5. 5
    Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age

    Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion-adjuvanted (AS03B) split-virion... by CS Waddington, N Andrews, K Hoschler, WT Walker, C Oeser, A Reiner, T John, S Wilkins, M Casey, PE Eccleston, RJ Allen, I Okike, S Ladhani, E Sheasby, P Waight, AC Collinson, PT Heath, A Finn, SN Faust, MD Snape, E Miller, AJ Pollard

    Published 2010-10-01
    Get full text
    Article

Search Tools: